HZNP
Loomis, Sayles & Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,591
| Closed | -$222K | – | 1022 |
|
|
2022
Q3 | $222K | Sell |
3,591
-255,525
| -99% | -$15.8M | ﹤0.01% | 461 |
|
|
2022
Q2 | $20.7M | Sell |
259,116
-90,470
| -26% | -$7.22M | 0.04% | 241 |
|
|
2022
Q1 | $36.8M | Buy |
349,586
+11,054
| +3% | +$1.16M | 0.05% | 187 |
|
|
2021
Q4 | $36.5M | Sell |
338,532
-3,433
| -1% | -$370K | 0.04% | 226 |
|
|
2021
Q3 | $37.5M | Buy |
341,965
+9,730
| +3% | +$1.07M | 0.05% | 214 |
|
|
2021
Q2 | $31.1M | Buy |
332,235
+12,508
| +4% | +$1.17M | 0.04% | 243 |
|
|
2021
Q1 | $29.4M | Sell |
319,727
-18,168
| -5% | -$1.67M | 0.04% | 235 |
|
|
2020
Q4 | $24.7M | Sell |
337,895
-1,752
| -0.5% | -$128K | 0.03% | 234 |
|
|
2020
Q3 | $26.4M | Sell |
339,647
-151,904
| -31% | -$11.8M | 0.04% | 186 |
|
|
2020
Q2 | $27.3M | Sell |
491,551
-912,729
| -65% | -$50.7M | 0.04% | 173 |
|
|
2020
Q1 | $41.6M | Buy |
1,404,280
+852
| +0.1% | +$25.2K | 0.09% | 87 |
|
|
2019
Q4 | $50.8M | Sell |
1,403,428
-37,734
| -3% | -$1.37M | 0.09% | 91 |
|
|
2019
Q3 | $39.2M | Buy |
1,441,162
+255,461
| +22% | +$6.96M | 0.08% | 108 |
|
|
2019
Q2 | $28.5M | Buy |
1,185,701
+19,468
| +2% | +$468K | 0.05% | 154 |
|
|
2019
Q1 | $30.8M | Buy |
1,166,233
+378,138
| +48% | +$9.99M | 0.06% | 130 |
|
|
2018
Q4 | $15.4M | Buy |
788,095
+786,314
| +44,150% | +$15.4M | 0.04% | 216 |
|
|
2018
Q3 | $35K | Sell |
1,781
-349
| -16% | -$6.86K | ﹤0.01% | 637 |
|
|
2018
Q2 | $35K | Sell |
2,130
-259
| -11% | -$4.26K | ﹤0.01% | 669 |
|
|
2018
Q1 | $34K | Buy |
+2,389
| New | +$34K | ﹤0.01% | 670 |
|